COSM · Cosmos Health Inc. · Documents

$0.30 +0.02 (+5.17%) At close · Nov 6

Market Cap

$29.17M

100.63M

Volume · Nov 6 1.05M Avg daily vol (3M) 3.01M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2023

Apr 12

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $50.35M ▼ 10.5% Net loss $13.83M Diluted EPS -$33.16

Mar 31

Late filing notice NT 10-K

Late filing notice

Mar 6

Current report 8-K Events of Feb 28

Entered into a material agreement, New debt or off-balance-sheet obligation

Feb 7

Current report 8-K Events of Feb 1

Director or officer change, or executive pay

Jan 18

Registration statement S-3

Registration statement

Jan 17

Current report 8-K

Entered into a material agreement

Jan 12

Current report 8-K Events of Jan 10

Current report

2022

Dec 20

Current report 8-K Events of Dec 19

Entered into a material agreement

Dec 19

Current report 8-K Events of Dec 15

Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change, Other events

Dec 16

Annual report 10-K/A FY2021, ended Dec 31

Annual report for FY2021

Revenue $56.24M ▲ 1.5% Net loss $7.96M Diluted EPS -$0.95

Dec 5

Current report 8-K Events of Dec 2

Shareholder vote results

Dec 1

Registration statement S-3/A

Registration statement

Nov 16

Current report 8-K Events of Nov 10

Financial results, Delisting notice or listing transfer

Nov 14

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $12.02M ▼ 11.6% Net loss $1.97M Diluted EPS -$0.08

Nov 7

Registration statement S-3/A

Registration statement

Oct 20

Proxy statement DEF 14A Meeting Nov 11, 2022

Proxy statement

Oct 18

Current report 8-K Events of Oct 17

Entered into a material agreement

Oct 14

Registration statement S-1/A

Registration statement

Oct 13

Registration statement S-1/A

Registration statement

Oct 11

Registration statement S-1/A

Registration statement

Oct 3

Current report 8-K

Entered into a material agreement, Unregistered sale of equity

Sep 27

Current report 8-K Events of Sep 26

Regulation FD disclosure

Sep 23

Proxy statement PRE 14A Meeting Nov 7, 2022

Proxy statement

Sep 21

Registration statement S-3

Registration statement

Sep 19

Registration statement S-1

Registration statement

Aug 23

Current report 8-K Events of Aug 22

Financial results

Aug 19

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $13.21M ▼ 11.0% Net loss $1.24M Diluted EPS -$0.93

Aug 16

Late filing notice NT 10-Q

Late filing notice

Jul 29

Current report 8-K Events of Jul 25

Delisting notice or listing transfer, Charter or bylaw amendment, or fiscal year change, Other events

Jul 25

Current report 8-K Events of Jul 19

Other events

Jun 7

Registration statement S-1/A

Registration statement

May 25

Registration statement S-1

Registration statement

May 18

Current report 8-K

Financial results

May 17

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $13.07M ▲ 12.5% Net income $203.35K Diluted EPS -$0.31

May 17

Late filing notice NT 10-Q

Late filing notice

Apr 28

Current report 8-K

Director or officer change, or executive pay

Apr 19

Current report 8-K

Current report

Apr 15

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $56.24M ▲ 1.5% Net loss $7.96M Diluted EPS -$0.95

Mar 31

Late filing notice NT 10-K

Late filing notice

Mar 1

Current report 8-K Events of Feb 24

Entered into a material agreement, Unregistered sale of equity, Charter or bylaw amendment, or fiscal year change, Other events

Feb 28

Current report 8-K Events of Feb 23

Other events

2021

Dec 20

Current report 8-K

Regulation FD disclosure

Dec 9

Current report 8-K/A Events of Dec 8

Unregistered sale of equity, Other events

Dec 8

Current report 8-K

Unregistered sale of equity, Other events

Nov 17

Current report 8-K Events of Nov 16

Other events

Nov 15

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $13.6M ▼ 5.3% Net loss $1.94M Diluted EPS -$0.11

Oct 12

Current report 8-K Events of Oct 4

Charter or bylaw amendment, or fiscal year change, Other events

Sep 21

Current report 8-K Events of Sep 17

Entered into a material agreement, Unregistered sale of equity, Other events

Aug 27

Current report 8-K Events of Aug 25

Unregistered sale of equity, Other events

Aug 16

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $14.85M ▲ 15.8% Net loss $2.38M Diluted EPS -$0.15

Showing 101–150 of 175 documents

Key facts CIK 1474167 CUSIP 221413305 13F (30d) 13 filings 9 filers Visit website Investor relations